2022
DOI: 10.5501/wjv.v11.i1.85
|View full text |Cite
|
Sign up to set email alerts
|

Role of vitamin D deficiency and comorbidities in COVID-19

Abstract: Recent manuscripts described the incidence of vitamin D hypovitaminosis in coronavirus disease 2019 (COVID-19) patients. Vitamin D deficiency is also common in patients with comorbidities that are associated with a poor COVID-19 prognosis. In this letter, we review the literature regarding the association of comorbidities, vitamin D deficiency, and COVID-19.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 47 publications
(45 reference statements)
0
1
0
Order By: Relevance
“…168,169 Our cause-effect analysis methodology addresses the limitations arising from the use of confidence in connectivity criteria and topological arguments for constructing and interpreting protein interaction networks relevant to vitamin D pharmacology. We have validated the relevance of the core VDR interactome by (1) using functional evidence to demonstrate that the proteins shown in Figure 3 are key drivers of vitamin D pharmacology, (2) identifying that perturbations of the regulatory scheme precipitate 590 vitamin D deficiencyassociated comorbidities (Figure 4), 170 and (3) that diseases identified using the core VDR interactome as the mechanism of action rationale express the characteristic physical abnormalities associated with vitamin D deficiency (Figures 5A and 5B). These observations illustrate that information flow-based, cause-effect analysis using protein swarms to integrate dynamic properties of proteins increases confidence in interactome construction for using proteomics data to influence decision-making.…”
Section: Discussionmentioning
confidence: 96%
“…168,169 Our cause-effect analysis methodology addresses the limitations arising from the use of confidence in connectivity criteria and topological arguments for constructing and interpreting protein interaction networks relevant to vitamin D pharmacology. We have validated the relevance of the core VDR interactome by (1) using functional evidence to demonstrate that the proteins shown in Figure 3 are key drivers of vitamin D pharmacology, (2) identifying that perturbations of the regulatory scheme precipitate 590 vitamin D deficiencyassociated comorbidities (Figure 4), 170 and (3) that diseases identified using the core VDR interactome as the mechanism of action rationale express the characteristic physical abnormalities associated with vitamin D deficiency (Figures 5A and 5B). These observations illustrate that information flow-based, cause-effect analysis using protein swarms to integrate dynamic properties of proteins increases confidence in interactome construction for using proteomics data to influence decision-making.…”
Section: Discussionmentioning
confidence: 96%